Scotiabank Initiates Coverage On Ocular Therapeutix with Sector Outperform Rating, Announces Price Target of $22

Benzinga · 10/16 14:03
Scotiabank analyst Greg Harrison initiates coverage on Ocular Therapeutix (NASDAQ:OCUL) with a Sector Outperform rating and announces Price Target of $22.